Paper Details

  1. Home
  2. Paper Details

Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.

Author: TonstadSerena

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Varenicline, an alpha4beta2 nicotinic receptor partial agonist, has shown promising results in Phase 3 studies for inducing smoking cessation and maintaining smoking abstinence. It has the potential to relieve nicotine craving and withdrawal symptoms while reducing the reinforcing effects of nicotine.
Paper Details　
Original Abstract of the Article :
Varenicline, an alpha4beta2 nicotinic receptor partial agonist, has the potential to relieve nicotine craving and withdrawal symptoms while reducing the reinforcing effects of nicotine. Phase 3 studies have evaluated the effects of varenicline on inducing smoking cessation and maintaining smoking ab...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/00005082-200611000-00004

データ提供：米国国立医学図書館（NLM）

Varenicline: A New Oasis in the Desert of Smoking Cessation

Smoking cessation is a challenging endeavor. This research evaluates the efficacy and safety of varenicline, a medication that acts as a partial agonist of the alpha4beta2 nicotinic receptor. Imagine a camel trying to break free from a dependence on a scarce water source – that's what it's like for smokers trying to quit. The researchers conducted phase 3 studies to assess the effects of varenicline on smoking cessation and abstinence.

Varenicline: A Potential Tool for Quitting Smoking

The study found that varenicline was effective in inducing smoking cessation and maintaining abstinence. It’s like finding a new, more reliable source of water in the desert – varenicline can help smokers break their dependence on cigarettes.

Varenicline and Smoking Cessation: A New Perspective

This research provides a new perspective on smoking cessation, offering a potentially effective medication to help smokers quit. It’s like discovering a new route through the desert – varenicline offers a different path to achieving freedom from nicotine dependence.

Dr. Camel's Conclusion

This research journey into the desert of smoking cessation highlights the importance of exploring new and innovative approaches to help smokers quit. It’s a reminder that we need to be open to new solutions, just like a wise camel seeking out new oases in a vast and unforgiving landscape.

Date :
  1. Date Completed 2007-04-03
  2. Date Revised 2019-11-10
Further Info :

Pubmed ID

17293731

DOI: Digital Object Identifier

10.1097/00005082-200611000-00004

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.